メインコンテンツにスキップ

Certara Announces Update of BaseCase Software, the Company’s Value Communication Platform

Major Release to Help Life Science Companies Maximize Go-to-Market Impact Princeton, N.J., 2021年7月8日. Certara, a global leader in biosimulation, today announced the release of BaseCase software version 2021.06, which updates the value communication software platform to include new capabilities that can provide biopharmaceutical and medical device companies greater commercial success for new therapies … Continued

Preparing for High Stakes Meetings; How to Best Convey a New Drug’s Value to Payers

This blog post includes key takeaways from the opening session of Certara’s first Strategic Evidence and Value Communications Symposium. This session featured the following four speakers: Shawn W. Bates is vice president of US sales and business development, Maximilian Vargas is senior director of US access strategy and account management, and Alex Solis is a … Continued

Using BaseCase to communicate product value in decentralized accounts

Securing market access in decentralized accounts was proving difficult for our client. Recognizing the need for more localized messaging, they hired an agency to transform their economic models and presentations into interactive apps. However, long timeframes and significant extra costs meant this wasn’t feasible long-term. They then turned to BaseCase, allowing them to develop such apps … Continued

Diagnostics and Devices: Accelerating Value Communication With Interactive Messaging

Learn how to accelerate decision-makers’ understanding of the value of diagnostic testing and medical devices to the health system. Two industry experts with over 35 years’ combined experience, Atlanta Kassatly, VP of Consulting at Certara, and Cynthia Doucet, President of OutcomeSynergy, discussed recent trends and issues that can hinder successful communication. Real-world solutions were reviewed … Continued

1 of 1
Powered by Translations.com GlobalLink OneLink Software